Speaker

Panos Kanavos is Professor in Practice in International Health Policy in the Department of Health Policy at the London School of Economics and Political Science, Deputy Director at LSE Health and Director of the Medical Technology Research Group (MTRG). He is also a Visiting Professor at SDA Bocconi in Milan, Italy and has previously been Harkness Fellow in Health Care Policy in the Department of Ambulatory Care and Prevention, Harvard Medical School. Panos’ work has had impact across geographies in addressing, among others, issues related to (a) health care financing reform and population health management;(b) the broad parameters of pharmaceutical policy and value assessment, (c) formulating policy framework for generic medicines, for advanced diagnostics, and for digital health technologies, (d) studying the clinical, economic, social and other criteria based on which countries make coverage decisions for new technologies, including medicines, medical devices and digital health tools;and (e) contributing to important policy developments, such as the drafting of the EU HTA Regulation. He was one of the co-authors of the EU impact assessment report, published in August 2017 by the European Commission, which provided the intellectual and empirical backdrop for the drafting and subsequent adoption of the EU HTA Regulation (HTAR). Panos has acted as advisor to a number of international governmental and non-governmental organizations, including the European Commission, the European Parliament, the World Bank, the World Health Organization, the Organization for Economic Co-operation and Development (OECD), and Ministries of Health/Health Insurance Organisations in over 40 countries. He has published extensively in the peer review literature.